Press Releases
Endo, Inc. Completes Acquisition of Endo International plc's Assets
Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution
Endo, Inc. Announces Pricing of $1.5 billion of Senior Secured Term Loan as Part of Endo's $2.5 billion Exit Financing
Endo, Inc. Announces Pricing of $1.0 billion of Senior Secured Notes
Endo, Inc. Announces Proposed Private Offering of Senior Secured Notes
Endo, Inc. Announces Proposed New Senior Secured Credit Facilities
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
Endo Announces Confirmation of Plan of Reorganization
Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution
ENDO REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS